BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28678825)

  • 1. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway.
    Zhang Z; Chang Y; Zhang J; Lu Y; Zheng L; Hu Y; Zhang F; Li X; Zhang W; Li X
    PLoS One; 2017; 12(7):e0179741. PubMed ID: 28678825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway.
    Zhuang S; Yu X; Lu M; Li Y; Ding N; Ding Y
    J Gynecol Oncol; 2020 Nov; 31(6):e91. PubMed ID: 33078596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
    Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
    Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling.
    Xie X; Pan J; Han X; Chen W
    Chem Biol Interact; 2019 Feb; 300():73-81. PubMed ID: 30639441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-93/HMGB3 regulatory axis exerts tumor suppressive effects in colorectal carcinoma cells.
    Gu M; Jiang Z; Li H; Peng J; Chen X; Tang M
    Exp Mol Pathol; 2021 Jun; 120():104635. PubMed ID: 33773992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF281 Regulates Cell Proliferation, Migration and Invasion in Colorectal Cancer through Wnt/β-Catenin Signaling.
    Qin CJ; Bu PL; Zhang Q; Chen JT; Li QY; Liu JT; Dong HC; Ren XQ
    Cell Physiol Biochem; 2019; 52(6):1503-1516. PubMed ID: 31112017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircMTO1 inhibits cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway in colorectal cancer.
    Ge Z; Li LF; Wang CY; Wang Y; Ma WL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8203-8209. PubMed ID: 30556859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/β-catenin signal pathway in colorectal cancer and predicts poor prognosis.
    Zhou C; Li Y; Wang G; Niu W; Zhang J; Wang G; Zhao Q; Fan L
    Pathol Res Pract; 2019 Jan; 215(1):57-67. PubMed ID: 30389319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group box 3 (HMGB3) silencing inhibits non-small cell lung cancer development through regulating Wnt/β-catenin pathway.
    Li Y; Ma Y; Zhang T; Feng C; Liu Y
    Biol Chem; 2020 Sep; 401(10):1191-1198. PubMed ID: 32386184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
    Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway.
    Yuan X; Sun X; Shi X; Wang H; Wu G; Jiang C; Yu D; Zhang W; Xue B; Ding Y
    Oncol Rep; 2017 Apr; 37(4):2398-2404. PubMed ID: 28259917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells.
    Xu M; Wang S; Qi Y; Chen L; Frank JA; Yang XH; Zhang Z; Shi X; Luo J
    Mol Carcinog; 2016 May; 55(5):1002-11. PubMed ID: 26014148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
    Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.